Phase 3 Vaccine Results: 4% Rise in Glenmark Pharma
Global leading research pharma company Glenmark Pharmaceuticals mentioned in a company statement, “Results from the Phase 3 trial showed numerical improvements for the primary efficacy endpoint with...